Puts Purchased on Cell Therapeutics (CTIC)
June 28, 2010 1:01 PM
Shares of Cell Therapeutics Inc. (NASDAQ: CTIC) are higher on the session by 24.70%, currently trading at $0.3993. The stock is rocketing higher today on no news that we are aware off.
Options traders are buying protection against a move back lower, though; the January 2011 $1.00 put was purchased 1,923 times, on the offer, a short while ago. Open interest on the strike is 10,248 contracts.
Put volume is now running at 2.14x the daily average.
Cell Therapeutics, Inc. develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs. Its research, development, acquisition and in-licensing activities concentrate on identifying and developing less toxic ways to treat cancer.
